Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform
The M2 isoform of pyruvate kinase (PKM2) is a potential antitumor therapeutic target. In this study, we designed and synthesised a series of 2, 3-didithiocarbamate substituted naphthoquinones as PKM2 inhibitors based on the lead compound 3k that we previously reported. Among them, compound 3f (IC50 ...
Saved in:
Main Authors: | Xianling Ning (Author), Hailong Qi (Author), Ridong Li (Author), Yan Jin (Author), Michael A. McNutt (Author), Yuxin Yin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting pyruvate kinase M2 for the treatment of kidney disease
by: Dan-Qian Chen, et al.
Published: (2024) -
SAR Study and Molecular Mechanism Investigation of Novel Naphthoquinone-furan-2-cyanoacryloyl Hybrids with Antitumor Activity
by: Pingxian Liu, et al.
Published: (2022) -
Design, synthesis and anticancer activity of naphthoquinone derivatives
by: Xiao-bao Shen, et al.
Published: (2020) -
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial
by: David A. Andrae, et al.
Published: (2023) -
Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation
by: Yun-zi Liu, et al.
Published: (2021)